Results 11 to 20 of about 7,031,181 (311)

Hematopoietic growth factors [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1996
Over the past ten years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Numerous studies performed to date have demonstrated significant benefits from the use of these cytokines.
R G, Bociek, J O, Armitage
openaire   +4 more sources

Pulsed Electric Fields for Valorization of Platelets with No Therapeutic Value towards a High Biomedical Potential Product—A Proof of Concept

open access: yesApplied Sciences, 2022
Nowadays, the standard media used in clinical-scale mesenchymal stem cell (MSC) production to supply hundreds of clinical trials uses animal-derived components as supplements, which raises several health concerns.
Daniela Salvador   +6 more
doaj   +1 more source

The effect of hyaluronic acid conditioned media on hDPSCs differentiation through CD44 and transforming growth factor-β1 expressions

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2023
Hyaluronic acid (HA) has the capability to influence dentin niche which is important in regenerative process. The CD44 as a specific receptor of HA was found to be related to dentin mineralization process. Meanwhile, transforming growth factor β1 (TGF-β1)
Dini Asrianti Bagio   +5 more
doaj   +1 more source

Effect on the canine Eck fistula liver of intraportal TGF‐β alone or with hepatic growth factors [PDF]

open access: yes, 1992
Transforming growth factor‐β canceled the hepatocyte proliferation caused by transforming growth factor‐α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast,
Alessandro Azzarone   +28 more
core   +1 more source

A Preliminary Study: Exploring Franchising Growth Factors of Franchisor and Franchisee

open access: yesJournal of Open Innovation: Technology, Market and Complexity, 2022
Previous literature has acknowledged franchising as a great way for businesses to expand into new areas and opportunities. It has become a popular option for those who are looking to start their businesses by choosing a well-known company’s brand name ...
Mohd Faizal Abdul Ghani   +3 more
doaj   +1 more source

Hepatocyte growth factor, a key tumor-promoting factor in the tumor microenvironment [PDF]

open access: yes, 2017
The tumor microenvironment plays a key role in tumor development and progression. Stromal cells secrete growth factors, cytokines and extracellular matrix proteins which promote growth, survival and metastatic spread of cancer cells.
Galemmo, Robert   +3 more
core   +2 more sources

Efficiency of autologous platelet-rich plasma for androgenic alopecia: a preliminary study

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Objective To evaluate the efficacy and safety of autologous platelet-rich plasma (PRP) in the treatment of androgenetic alopecia and to investigate the correlation between concentrations of growth factors and efficacy.
Jie ZHANG   +4 more
doaj   +1 more source

Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients

open access: yesThe International Journal of Biological Markers, 2012
Transforming growth factor betas (TGF-βs) are multifunctional cytokines with a biphasic role in breast tumorigenesis, acting as tumor suppressors at early stages while stimulating tumor progression at later stages (TGF-β switch).
Heena Dave   +3 more
doaj   +1 more source

Inhibiting epidermal growth factor receptor at a distance. [PDF]

open access: yes, 2014
The epidermal growth factor receptor (EGFR) tyrosine kinase is implicated in a large number of human cancers. Most EGFR inhibitors target the extracellular, growth factor-binding domain or the intracellular, ATP-binding domain. Here we describe molecules
Denton, Elizabeth   +2 more
core   +2 more sources

The GLP‐1/GIP dual‐receptor agonist DA5‐CH inhibits the NF‐κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP‐1 single‐receptor agonist NLY01

open access: yesBrain and Behavior, 2021
The GLP‐1 receptor agonist exendin‐4 has recently shown good effects in a phase II clinical trial in Parkinson's disease (PD) patients. Here, a comparison of the new GLP‐1/GIP dual receptor agonist DA5‐CH and NLY01, a 40 kDa pegylated form of exendin‐4 ...
MiaoJun Lv   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy